THE UNIVERSITY OF QUEENSLAND

- Country
- 🇦🇺Australia
- Ownership
- Private
- Established
- 1909-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.uq.edu.au
Ceftolozane-tazobactam Versus Meropenem for ESBL and AmpC-producing Enterobacterales Bloodstream Infection
- Conditions
- Bacteremia Caused by Gram-Negative Bacteria
- Interventions
- Drug: Ceftolozane-Tazobactam
- First Posted Date
- 2020-01-23
- Last Posted Date
- 2022-05-19
- Lead Sponsor
- The University of Queensland
- Registration Number
- NCT04238390
- Locations
- 🇦🇺
John Hunter Hospital, Newcastle, New South Wales, Australia
🇦🇺Royal Prince Alfred, Sydney, New South Wales, Australia
🇦🇺Westmead Hospital, Sydney, New South Wales, Australia
Vascular Access Outcome Measure for Function: a vaLidation Study In haemoDialysis
- Conditions
- Vascular Access ComplicationHemodialysis Access Failure (Disorder)
- First Posted Date
- 2019-05-31
- Last Posted Date
- 2024-05-10
- Lead Sponsor
- The University of Queensland
- Target Recruit Count
- 702
- Registration Number
- NCT03969225
- Locations
- 🇦🇺
Princess Alexandra Hospital, Brisbane, Queensland, Australia
🇦🇺Mackay Hospital, Mackay, Queensland, Australia
🇦🇺Mater Hospital, Brisbane, Australia
RCT Cefiderocol vs BAT for Treatment of Gram Negative BSI
- Conditions
- Bloodstream Infections
- Interventions
- Other: Best Available Therapy
- First Posted Date
- 2019-03-11
- Last Posted Date
- 2024-02-13
- Lead Sponsor
- The University of Queensland
- Target Recruit Count
- 513
- Registration Number
- NCT03869437
- Locations
- 🇦🇺
Westmead Hospital, Sydney, New South Wales, Australia
🇦🇺Princess Alexandra Hospital, Brisbane, Queensland, Australia
🇦🇺Royal Brisbane and Womens Hospital, Brisbane, Queensland, Australia
Better Evidence for Selecting Transplant Fluids
- Conditions
- Delayed Graft FunctionEnd Stage Kidney DiseaseKidney Transplant; Complications
- Interventions
- Drug: 0.9% SODIUM CHLORIDE 9g/L injection BP
- First Posted Date
- 2019-02-04
- Last Posted Date
- 2024-10-15
- Lead Sponsor
- The University of Queensland
- Target Recruit Count
- 808
- Registration Number
- NCT03829488
- Locations
- 🇦🇺
Sydney Children's Hospital, Randwick, New South Wales, Australia
🇦🇺Prince of Wales Hospital, Sydney, New South Wales, Australia
🇦🇺Royal Prince Alfred Hospital, Sydney, New South Wales, Australia
Targeted Education ApproaCH to Improve Peritoneal Dialysis Outcomes Trial
- Conditions
- Kidney Disease, ChronicPeritoneal Dialysis Catheter-Associated PeritonitisPeritoneal Dialysis Catheter Exit Site InfectionPeritoneal Dialysis Catheter Tunnel Infection
- First Posted Date
- 2019-01-25
- Last Posted Date
- 2024-05-10
- Lead Sponsor
- The University of Queensland
- Target Recruit Count
- 1500
- Registration Number
- NCT03816111
- Locations
- 🇦🇺
Canberra Hospital, Canberra, Australian Capital Territory, Australia
🇦🇺St Vincent's Hospital Sydney, Darlinghurst, New South Wales, Australia
🇦🇺Gosford Hospital, Gosford, New South Wales, Australia
A Novel Intervention to Promote Engagement in Physical Activity for Individuals With Whiplash Associated Disorder
- Conditions
- Sedentary LifestyleWhiplash Injuries
- First Posted Date
- 2018-11-05
- Last Posted Date
- 2019-04-19
- Lead Sponsor
- The University of Queensland
- Target Recruit Count
- 6
- Registration Number
- NCT03729856
- Locations
- 🇦🇺
The University of Queensland, Brisbane, Queensland, Australia
Penicillin Against Flucloxacillin Treatment Evaluation
- Conditions
- Staphylococcus Aureus
- Interventions
- First Posted Date
- 2018-08-15
- Last Posted Date
- 2022-11-16
- Lead Sponsor
- The University of Queensland
- Registration Number
- NCT03632642
- Locations
- 🇦🇺
Brisbane Private Hospital, Brisbane, Queensland, Australia
Pragmatic Randomised Trial of High Or Standard PHosphAte Targets in End-stage Kidney Disease (PHOSPHATE)
- Conditions
- HyperphosphatemiaKidney Failure, Chronic
- Interventions
- First Posted Date
- 2018-06-29
- Last Posted Date
- 2025-07-01
- Lead Sponsor
- The University of Queensland
- Target Recruit Count
- 3600
- Registration Number
- NCT03573089
- Locations
- 🇦🇺
Royal Prince Alfred Hosptial, Camperdown, New South Wales, Australia
🇦🇺Nepean Hospital, Kingswood, New South Wales, Australia
🇦🇺St George Hospital, Kogarah, New South Wales, Australia
Screening Anti-Fungal Exposure in Intensive Care Units
- Conditions
- Antifungal Agents
- First Posted Date
- 2017-05-02
- Last Posted Date
- 2018-06-21
- Lead Sponsor
- The University of Queensland
- Target Recruit Count
- 150
- Registration Number
- NCT03136926
- Locations
- 🇺🇸
Oschner Medical Center, New Orleans, Louisiana, United States
🇦🇺Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia
🇦🇺The Royal Melbourne Hospital, Melbourne, Victoria, Australia
International Lung Screen Trial (ILST)
- Conditions
- Non-small Cell Lung CancerThoracic NeoplasmsNeoplasms by SiteLung DiseasesRespiratory Tract DiseasesLung NeoplasmsRespiratory Tract NeoplasmsNeoplasmsSmokers at Risk of Lung Cancer
- First Posted Date
- 2016-08-18
- Last Posted Date
- 2023-12-05
- Lead Sponsor
- The University of Queensland
- Target Recruit Count
- 2000
- Registration Number
- NCT02871856
- Locations
- 🇦🇺
St Vincent's Hospital, Sydney, New South Wales, Australia
🇦🇺The Prince Charles Hospital, Brisbane, Queensland, Australia
🇦🇺Royal Melbourne Hospital, Melbourne, Victoria, Australia